Vendor, New Taipei City, TWN
Pharmacology Discovery Services Taiwan, Ltd.
UEI MXP1NVQ8C1J8, CAGE SCSX7
16 awards and $2,578,190 obligated between January 29, 2024 and September 30, 2026, 100% under full and open competition, against 7.8 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $1,336,038 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | $1,242,152 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 16 |
| Delivery Order | 15 |
Hear when Pharmacology Discovery Services Taiwan, Ltd. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Pharmacology Discovery Services Taiwan, Ltd. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $545,542
- Soonest
- September 29, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to National Institutes of Health, by dollars.
| Fisher Bioservices Inc.Rockville, MD | $101,554,099 |
| PPD Development LPWilmington, NC | $65,307,629 |
| Seattle Children'S HospitalSeattle, WA | $61,525,979 |
| Alpha Genesis Inc.Yemassee, SC | $55,645,143 |
| Psychogenics Inc.Paramus, NJ | $36,035,836 |
| Rho Federal Systems Division Inc.Durham, NC | $35,268,211 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93026F00002Delivery Order, July 21, 2026, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Mouse Model of Neisseria Gonorrhoeae InfectionNAICS 541714, PSC AN11 | $621,336 |
| 75N93026F00003Delivery Order, September 30, 2026, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Therapeutic Testing in Murine Models of Bacterial InfectionNAICS 541714, PSC AN11 | $545,542 |
| 75N93024F00003Delivery Order, July 10, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | A94 - Testing in Murine Models of Bacterial InfectionNAICS 541711, PSC AN11 | $503,403 |
| 75N93023F00002Delivery Order, February 16, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | Pre-Clinical Models of Infectious DiseaseNAICS 541711, PSC AN11 | $391,673 |
| 75N93024F00002Delivery Order, July 11, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Mouse Model of Neisseria Gonorrhoeae InfectionNAICS 541711, PSC AN11 | $331,260 |
| 75N93026F00001Delivery Order, April 16, 2026, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | A12 - Murine Models of Uti Infection Caused by Antibiotic-Resistant BacteriaNAICS 541714, PSC AN11 | $169,160 |
| 75N93023F00001Delivery Order, March 7, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Murine Models of Uti Infection Caused by Antibiotic-Resistant BacteriaNAICS 541711, PSC AN11 | $141,700 |
| 75N93024D00017July 10, 2024, Full and Open Competition, 76 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | Pre-Clinical Models of Infectious Diseases - Task Area aNAICS 541714, PSC AN11 | $0 |
| 75N93021F00003Delivery Order, February 6, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate the Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$1 |
| 75N93019F00131Delivery Order, January 29, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$1,750 |
| 75N93022F00003Delivery Order, January 29, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$7,800 |
| 75N93022F00002Delivery Order, January 29, 2024, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$9,220 |
| 75N93021F00002Delivery Order, January 29, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$14,440 |
| 75N93020F00159Delivery Order, January 29, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$17,100 |
| 75N93021F00001Delivery Order, January 29, 2024, Full and Open Competition, 2 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate the Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$23,988 |
| 75N93018F00003Delivery Order, April 15, 2024, Full and Open Competition, 5 offers | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate Remaining Funds and Administratively Close the Task Order.NAICS 541711, PSC AN11 | -$51,585 |
- Places of performance
- Maryland
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 25 across 16 awards